Product Information
LOMAIRA 8 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.6151 per EA under NDC 10702000109. Its NADAC has been published 206 times since Jul 20, 2022.
Strength
8 mg/1
Manufacturer
KVK-Tech Inc.NDC
10702000109
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203495On Market Since
9/12/2016
Pharmacological Classes
Price Statistics
The NADAC for LOMAIRA 8 MG TABLET has been published 206 times since Jul 20, 2022, and over the history we have for it it has risen 19.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6151 per EA |
|---|---|
| All-time high | $0.6170 (Jul 16, 2025) |
| All-time low | $0.5119 (Jan 18, 2023) |
| 52-week high | $0.6170 |
| 52-week low | $0.6139 |
| Median price | $0.5649 |
| Average price | $0.5660 |
| Largest weekly change | +6.9% (Apr 19, 2023) |
| Weeks tracked | 206 |
| Tracking since | Jul 20, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LOMAIRA 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LOMAIRA 8 MG TABLET, manufactured by KVK-Tech Inc., is $0.6151 per EA (NDC 10702000109), effective Jun 24, 2026.
How has the price of LOMAIRA 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for LOMAIRA 8 MG TABLET has risen 19.4%. It has been tracked across 206 weekly CMS publications since Jul 20, 2022.
What are the highest and lowest recorded NADAC prices for LOMAIRA 8 MG TABLET?
Since Jul 20, 2022, the NADAC for LOMAIRA 8 MG TABLET has ranged from a low of $0.5119 (Jan 18, 2023) to a high of $0.6170 (Jul 16, 2025), with a median of $0.5649 per EA.
Are there cheaper alternatives to LOMAIRA 8 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as LOMAIRA 8 MG TABLET, but none are currently priced below it.
Who manufactures LOMAIRA 8 MG TABLET?
LOMAIRA 8 MG TABLET (NDC 10702000109) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification